Agenus reported $65.49M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Agenus AGEN:US $ 65.49M 4.09M
Amgen AMGN:US $ 4.42B 680M
AstraZeneca AZN:LN 10.23B 280M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Celldex Therapeutics CLDX:US $ 36.56M 13.13M
Chemocentryx CCXI:US $ 43.34M 355K
CSL CSL:AU $ 3.83B 28M
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Glaxosmithkline GSK:US 5.85B 1.13B
Immunogen IMGN:US $ 75.22M 14.28M
Intrexon XON:US $ 27.07M 22.84M
Jiangsu Hengrui Me. 600276:CH 4.11B 2B
Johnson & Johnson JNJ:US $ 18.18B 616M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Macrogenics MGNX:US $ 67.82M 9.92M
Merck MRK:GR 4.39B 366M
Merk MRK:US $ 9666M 666M
Northwest Biotherapeutics NWBO:US 12.28M 1.58M
Novartis NOVN:VX 10.86B 895M
Novavax NVAX:US $ 668.88M 174.21M
Pfizer PFE:US $ 15640M 148M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Rigel Pharmaceuticals RIGL:US $ 42.78M 212K
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Veracyte VCYT:US $ 83.6M 566K
YTE INCY:US $ 656.97M 40.27M